BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30520240)

  • 1. Targeted Feature Extraction in MALDI Mass Spectrometry Imaging to Discriminate Proteomic Profiles of Breast and Ovarian Cancer.
    Cordero Hernandez Y; Boskamp T; Casadonte R; Hauberg-Lotte L; Oetjen J; Lachmund D; Peter A; Trede D; Kriegsmann K; Kriegsmann M; Kriegsmann J; Maass P
    Proteomics Clin Appl; 2019 Jan; 13(1):e1700168. PubMed ID: 30520240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Class Prediction Model to Discriminate Pancreatic Ductal Adenocarcinoma from Pancreatic Neuroendocrine Tumor by MALDI Mass Spectrometry Imaging.
    Casadonte R; Kriegsmann M; Perren A; Baretton G; Deininger SO; Kriegsmann K; Welsch T; Pilarsky C; Kriegsmann J
    Proteomics Clin Appl; 2019 Jan; 13(1):e1800046. PubMed ID: 30548962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-to-Site Reproducibility and Spatial Resolution in MALDI-MSI of Peptides from Formalin-Fixed Paraffin-Embedded Samples.
    Ly A; Longuespée R; Casadonte R; Wandernoth P; Schwamborn K; Bollwein C; Marsching C; Kriegsmann K; Hopf C; Weichert W; Kriegsmann J; Schirmacher P; Kriegsmann M; Deininger SO
    Proteomics Clin Appl; 2019 Jan; 13(1):e1800029. PubMed ID: 30408343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MALDI-Imaging for Classification of Epithelial Ovarian Cancer Histotypes from a Tissue Microarray Using Machine Learning Methods.
    Klein O; Kanter F; Kulbe H; Jank P; Denkert C; Nebrich G; Schmitt WD; Wu Z; Kunze CA; Sehouli J; Darb-Esfahani S; Braicu I; Lellmann J; Thiele H; Taube ET
    Proteomics Clin Appl; 2019 Jan; 13(1):e1700181. PubMed ID: 30471200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new classification method for MALDI imaging mass spectrometry data acquired on formalin-fixed paraffin-embedded tissue samples.
    Boskamp T; Lachmund D; Oetjen J; Cordero Hernandez Y; Trede D; Maass P; Casadonte R; Kriegsmann J; Warth A; Dienemann H; Weichert W; Kriegsmann M
    Biochim Biophys Acta Proteins Proteom; 2017 Jul; 1865(7):916-926. PubMed ID: 27836618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How Suitable is Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight for Metabolite Imaging from Clinical Formalin-Fixed and Paraffin-Embedded Tissue Samples in Comparison to Matrix-Assisted Laser Desorption/Ionization-Fourier Transform Ion Cyclotron Resonance Mass Spectrometry?
    Buck A; Balluff B; Voss A; Langer R; Zitzelsberger H; Aichler M; Walch A
    Anal Chem; 2016 May; 88(10):5281-9. PubMed ID: 27065343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) identifies proteomic differences in breast-cancer-associated stroma.
    Dekker TJ; Balluff BD; Jones EA; Schöne CD; Schmitt M; Aubele M; Kroep JR; Smit VT; Tollenaar RA; Mesker WE; Walch A; McDonnell LA
    J Proteome Res; 2014 Nov; 13(11):4730-8. PubMed ID: 24762205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging mass spectrometry to discriminate breast from pancreatic cancer metastasis in formalin-fixed paraffin-embedded tissues.
    Casadonte R; Kriegsmann M; Zweynert F; Friedrich K; Baretton G; Otto M; Deininger SO; Paape R; Belau E; Suckau D; Aust D; Pilarsky C; Kriegsmann J
    Proteomics; 2014 Apr; 14(7-8):956-64. PubMed ID: 24482424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MALDI Imaging for Proteomic Painting of Heterogeneous Tissue Structures.
    Kriegsmann J; Kriegsmann M; Kriegsmann K; Longuespée R; Deininger SO; Casadonte R
    Proteomics Clin Appl; 2019 Jan; 13(1):e1800045. PubMed ID: 30471204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In MALDI-Mass Spectrometry Imaging on Formalin-Fixed Paraffin-Embedded Tissue Specimen Section Thickness Significantly Influences m/z Peak Intensity.
    Longuespée R; Kriegsmann K; Cremer M; Zgorzelski C; Casadonte R; Kazdal D; Kriegsmann J; Weichert W; Schwamborn K; Fresnais M; Schirmacher P; Kriegsmann M
    Proteomics Clin Appl; 2019 Jan; 13(1):e1800074. PubMed ID: 30216687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digital PCR After MALDI-Mass Spectrometry Imaging to Combine Proteomic Mapping and Identification of Activating Mutations in Pulmonary Adenocarcinoma.
    Kazdal D; Longuespée R; Dietz S; Casadonte R; Schwamborn K; Volckmar AL; Kriegsmann J; Kriegsmann K; Fresnais M; Stenzinger A; Sültmann H; Warth A; Kriegsmann M
    Proteomics Clin Appl; 2019 Jan; 13(1):e1800034. PubMed ID: 30216696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detergent addition to tryptic digests and ion mobility separation prior to MS/MS improves peptide yield and protein identification for in situ proteomic investigation of frozen and formalin-fixed paraffin-embedded adenocarcinoma tissue sections.
    Djidja MC; Francese S; Loadman PM; Sutton CW; Scriven P; Claude E; Snel MF; Franck J; Salzet M; Clench MR
    Proteomics; 2009 May; 9(10):2750-63. PubMed ID: 19405023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular profiles of thyroid cancer subtypes: Classification based on features of tissue revealed by mass spectrometry imaging.
    Pietrowska M; Diehl HC; Mrukwa G; Kalinowska-Herok M; Gawin M; Chekan M; Elm J; Drazek G; Krawczyk A; Lange D; Meyer HE; Polanska J; Henkel C; Widlak P
    Biochim Biophys Acta Proteins Proteom; 2017 Jul; 1865(7):837-845. PubMed ID: 27760391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Proteomic Markers in Head and Neck Cancer Using MALDI-MS Imaging, LC-MS/MS, and Immunohistochemistry.
    Hoffmann F; Umbreit C; Krüger T; Pelzel D; Ernst G; Kniemeyer O; Guntinas-Lichius O; Berndt A; von Eggeling F
    Proteomics Clin Appl; 2019 Jan; 13(1):e1700173. PubMed ID: 30411850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A MALDI-Mass Spectrometry Imaging method applicable to different formalin-fixed paraffin-embedded human tissues.
    De Sio G; Smith AJ; Galli M; Garancini M; Chinello C; Bono F; Pagni F; Magni F
    Mol Biosyst; 2015 Jun; 11(6):1507-14. PubMed ID: 25592401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tryptic peptide reference data sets for MALDI imaging mass spectrometry on formalin-fixed ovarian cancer tissues.
    Meding S; Martin K; Gustafsson OJ; Eddes JS; Hack S; Oehler MK; Hoffmann P
    J Proteome Res; 2013 Jan; 12(1):308-15. PubMed ID: 23214983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter Evaluation of Tissue Classification by Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging.
    Deininger SO; Bollwein C; Casadonte R; Wandernoth P; Gonçalves JPL; Kriegsmann K; Kriegsmann M; Boskamp T; Kriegsmann J; Weichert W; Schirmacher P; Ly A; Schwamborn K
    Anal Chem; 2022 Jun; 94(23):8194-8201. PubMed ID: 35658398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MALDI Imaging Combined with Laser Microdissection-Based Microproteomics for Protein Identification: Application to Intratumor Heterogeneity Studies.
    Longuespée R; Alberts D; Baiwir D; Mazzucchelli G; Smargiasso N; De Pauw E
    Methods Mol Biol; 2018; 1788():297-312. PubMed ID: 29224050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mass spectrometry imaging technology and its application in breast cancer research].
    Zhang M; Zhang Y; Wang H; Li N; Li B; Xiao H; Bian W; Cai Z
    Se Pu; 2021 Jun; 39(6):578-587. PubMed ID: 34227318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visualizing Energy Charge in Breast Carcinoma Tissues by MALDI Mass-spectrometry Imaging Profiles of Low-molecular-weight Metabolites.
    Torata N; Kubo M; Miura D; Ohuchida K; Mizuuchi Y; Fujimura Y; Hayakawa E; Kai M; Oda Y; Mizumoto K; Hashizume M; Nakamura M
    Anticancer Res; 2018 Jul; 38(7):4267-4272. PubMed ID: 29970560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.